CARLONI, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 243
EU - Europa 161
AS - Asia 91
AF - Africa 10
Totale 505
Nazione #
US - Stati Uniti d'America 243
IT - Italia 60
SG - Singapore 37
SE - Svezia 22
CN - Cina 20
IN - India 20
DE - Germania 17
CH - Svizzera 14
GB - Regno Unito 13
IE - Irlanda 12
FI - Finlandia 9
JO - Giordania 6
TG - Togo 5
ID - Indonesia 4
NG - Nigeria 4
NL - Olanda 3
RU - Federazione Russa 3
TR - Turchia 3
UA - Ucraina 2
AT - Austria 1
BE - Belgio 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DK - Danimarca 1
FR - Francia 1
PH - Filippine 1
PL - Polonia 1
Totale 505
Città #
Chandler 41
Singapore 35
Fairfield 29
Ashburn 19
Bern 13
Bologna 12
Dublin 12
Princeton 10
Redmond 10
Southend 9
Boardman 8
Hyderabad 8
New York 8
Santa Clara 8
Seattle 8
Florence 7
Amman 6
Helsinki 6
Lomé 5
Abeokuta 4
Beijing 4
Cambridge 4
Fontanelice 4
Jakarta 4
Rome 4
Wilmington 4
Woodbridge 4
Ann Arbor 3
Des Moines 3
Houston 3
Lappeenranta 3
Pune 3
Turin 3
Berlin 2
Fulham 2
Haikou 2
Parma 2
Perugia 2
Zhengzhou 2
Abidjan 1
Altedo 1
Brussels 1
Bühl 1
Casalmaggiore 1
Davao City 1
Gmina Zabierzów 1
Groningen 1
Guangzhou 1
Hounslow 1
Istanbul 1
Modena 1
Monmouth Junction 1
Mountain View 1
Mülheim 1
Ningbo 1
Nuremberg 1
Provo 1
Saint Petersburg 1
Salt Lake City 1
San Diego 1
Siena 1
Sofia 1
Tulsa 1
Washington 1
Totale 341
Nome #
Pancreatic mucinous cystadenocarcinoma in a patient harbouring BRCA1 germline mutation effectively treated with olaparib: A case report 123
Long-term survival of two patients with recurrent pancreatic acinar cell carcinoma treated with radiofrequency ablation: A case report. 100
Searching for novel multimodal treatments in oligometastatic pancreatic cancer 99
Dual immune checkpoint blockade in hepatocellular carcinoma: where do we stand? 76
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumor Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes 67
Immunotherapy in Pancreatic Cancer: Why Do We Keep Failing? A Focus on Tumour Immune Microenvironment, Predictive Biomarkers and Treatment Outcomes 38
Atezolizumab-bevacizumab plus Y-90 TARE for the treatment of hepatocellular carcinoma: preclinical rationale and ongoing clinical trials 21
Appropriateness of Mini-Invasive Approaches for Nausea and Vomiting Refractory to Medical Therapy in Palliative Care Setting: A Case Report 20
Totale 544
Categoria #
all - tutte 2.133
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.133


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 0 33 3 4 6 14 12
2021/2022117 9 1 1 6 7 2 3 12 13 12 35 16
2022/2023175 14 20 6 12 12 16 4 11 30 14 21 15
2023/202479 13 5 7 6 7 20 0 7 0 3 9 2
2024/2025101 20 24 26 12 19 0 0 0 0 0 0 0
Totale 544